Mast cells play a protumorigenic role in primary cutaneous lymphoma.

Abstract:

:Primary cutaneous lymphomas (PCLs) are clonal T- or B-cell neoplasms, which originate in the skin. In recent years, mast cells were described as regulators of the tumor microenvironment in different human malignancies. Here, we investigated the role of mast cells in the tumor microenvironment of PCL. We found significantly increased numbers of mast cells in skin biopsies from patients with cutaneous T-cell lymphoma (CTCL) and cutaneous B-cell lymphoma (CBCL). Mast cell infiltration was particularly prominent in the periphery, at lymphoma rims. Interestingly, CTCL and CBCL patients with a progressive course showed higher mast cell counts than stable patients, and mast cell numbers in different stages of CTCL correlated positively with disease progression. In addition, mast cell numbers positively correlated with microvessel density. Incubating primary CTCL cells with mast cell supernatant, we observed enhanced proliferation and production of cytokines. In line with our in vitro experiments, in a mouse model of cutaneous lymphoma, tumor growth in mast cell-deficient transgenic mice was significantly decreased. Taken together, these experiments show that mast cells play a protumorigenic role in CTCL and CBCL. Our data provide a rationale for exploiting tumor-associated mast cells as a prognostic marker and therapeutic target in PCL.

journal_name

Blood

journal_title

Blood

authors

Rabenhorst A,Schlaak M,Heukamp LC,Förster A,Theurich S,von Bergwelt-Baildon M,Büttner R,Kurschat P,Mauch C,Roers A,Hartmann K

doi

10.1182/blood-2012-03-415638

subject

Has Abstract

pub_date

2012-09-06 00:00:00

pages

2042-54

issue

10

eissn

0006-4971

issn

1528-0020

pii

blood-2012-03-415638

journal_volume

120

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Serum hepatitis C virus sequences in posttransfusion non-A, non-B hepatitis.

    abstract::We investigated 17 patients (12 males and 5 females, ages 2 to 57 years old) with posttransfusion non-A, non-B hepatitis to determine relationships between clinical courses and hepatitis C virus (HCV) markers. The patients were grouped according to time course of abnormal serum alanine aminotransferase (ALT) levels in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Shibata M,Morishima T,Kudo T,Maki T,Maki S,Nagai Y

    更新日期:1991-03-15 00:00:00

  • Autologous and MHC class I-negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma.

    abstract::Cytokine gene-modified tumor cells have increased immunogenicity and retain the antigenic repertoire of a particular neoplasia. However, practical concerns have led to an increased interest in allogeneic gene-transduced bystander cells as a broader source of cytokines for autologous tumor cell-based vaccines. Here, we...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0991

    authors: Curti A,Parenza M,Colombo MP

    更新日期:2003-01-15 00:00:00

  • Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment.

    abstract::Expression of the arterial marker molecule ephrinB2 in endothelial cells is a prerequisite for adequate remodeling processes of the developing or angiogenic vasculature. Although its role in these processes has been extensively studied, the impact of ephrinB2 on the remodeling of adult arteries is largely unknown. To ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-12-128835

    authors: Korff T,Braun J,Pfaff D,Augustin HG,Hecker M

    更新日期:2008-07-01 00:00:00

  • Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.

    abstract::Increased expression levels of miR-181 family members have been shown to be associated with favorable outcome in patients with cytogenetically normal acute myeloid leukemia. Here we show that increased expression of miR-181a and miR-181b is also significantly (P < .05; Cox regression) associated with favorable overall...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-386235

    authors: Li Z,Huang H,Li Y,Jiang X,Chen P,Arnovitz S,Radmacher MD,Maharry K,Elkahloun A,Yang X,He C,He M,Zhang Z,Dohner K,Neilly MB,Price C,Lussier YA,Zhang Y,Larson RA,Le Beau MM,Caligiuri MA,Bullinger L,Valk PJ,Del

    更新日期:2012-03-08 00:00:00

  • Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft-versus-leukemia effect.

    abstract::Peripheral blood progenitor cells (PBPCs) are increasingly being used to replace bone marrow cells (BMCs) as a source of hematopoietic stem cells also in the field of allogeneic transplantation. Whereas it is well known that PBPC grafts and BM differ significantly in progenitor cell content and lymphocyte dose, the cl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Glass B,Uharek L,Zeis M,Dreger P,Löffler H,Steinmann J,Schmitz N

    更新日期:1997-08-15 00:00:00

  • Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines.

    abstract::Erythropoietin (EPO) is the hormone necessary for development of erythrocytes from immature erythroid cells. EPO activates Jun N-terminal kinase (JNK), a member of the mitogen-activated protein kinase (MAPK) family in the EPO-dependent murine erythroid HCD57 cells. Therefore, we tested if JNK activity supported prolif...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1754

    authors: Jacobs-Helber SM,Sawyer ST

    更新日期:2004-08-01 00:00:00

  • Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses.

    abstract::Significant comorbidites and lethality complicate GVHD and its treatment. Targeting the cytokine milieu may improve GVHD control; and IL6 is an attractive candidate, given its role in dendritic cell activation and T-cell differentiation. Tocilizumab is a humanized mAb to IL6-receptor-α (IL6R-α), which is Food and Drug...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-363390

    authors: Betts BC,St Angelo ET,Kennedy M,Young JW

    更新日期:2011-11-10 00:00:00

  • Parallel tubular arrays in severe combined immunodeficiency disease: an ultrastructural study of peripheral blood lymphocytes.

    abstract::The ultrastructure of the lymphocytes from three children with severe combined immunodeficiency disease (SCID) is described. Parallel tubular arrays (PTA) were found in a large percentage of circulating lymphocytes (53%, 41%, and 13%) in three SCID patients when compared to age-matched controls. The size of these incl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Payne CM,Jones JF,Sieber OF Jr,Fulginiti VA

    更新日期:1977-07-01 00:00:00

  • Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells.

    abstract::We evaluated the potential role of photoradiation therapy with a benzoporphyrin derivative, monoacid ring A (BPD-MA), and dihematoporphyrin ether (DHE), for the ex vivo purging of residual tumor cells from autologous bone marrow (BM) grafts. BPD-MA and DHE photosensitizing activity was tested against two human large-c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lemoli RM,Igarashi T,Knizewski M,Acaba L,Richter A,Jain A,Mitchell D,Levy J,Gulati SC

    更新日期:1993-02-01 00:00:00

  • Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells.

    abstract::Dendritic cells (DCs) are specialized antigen-presenting cells that monitor the antigenic environment and activate naive T cells. The role of DCs is not only to sense danger but also to tolerize the immune system to antigens encountered in the absence of maturation/inflammatory stimuli. Indeed, if a naive T cell encou...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1211

    authors: Levings MK,Gregori S,Tresoldi E,Cazzaniga S,Bonini C,Roncarolo MG

    更新日期:2005-02-01 00:00:00

  • Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells.

    abstract::In the current study, we investigated whether the naive, poly I:C or interleukin-2 (IL-2)-induced natural killer (NK)/lymphokine-activated killer (LAK) cells use perforin and/or Fas ligand (FasL) to mediated cytotoxicity. We correlated these findings with the ability of mice to reject syngeneic Fas+ and Fas- tumor cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bradley M,Zeytun A,Rafi-Janajreh A,Nagarkatti PS,Nagarkatti M

    更新日期:1998-12-01 00:00:00

  • Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12.

    abstract::Interleukin-12 (IL-12) inhibits angiogenesis in vivo by inducing interferon-gamma (IFN-gamma) and other downstream mediators. Here, we report that neutralization of natural killer (NK) cell function with antibodies to either asialo GM1 or NK 1.1 reversed IL-12 inhibition of basic fibroblast growth factor (bFGF)-induce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yao L,Sgadari C,Furuke K,Bloom ET,Teruya-Feldstein J,Tosato G

    更新日期:1999-03-01 00:00:00

  • Rearrangement of both immunoglobulin and T-cell receptor genes in a prolymphocytic variant of hairy cell leukemia patient resistant to interferon-alpha.

    abstract::We describe a patient with the so-called "prolymphocytic variant" form of hairy cell leukemia (HCL) resistant to treatment with interferon-alpha (IFN-alpha). Analysis of immunoglobulin (Ig) and T-cell receptor-beta (TCR beta) gene rearrangements from serial peripheral blood mononuclear cell specimens (MNCs) confirmed ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Giardina SL,Young HA,Faltynek CR,Jaffe ES,Clark JW,Steis RG,Urba WJ,Mathieson BJ,Gralnick H,Lawrence J

    更新日期:1988-11-01 00:00:00

  • Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.

    abstract::Myeloproliferative neoplasms (MPNs) are a group of clonal disorders characterized by aberrant hematopoietic proliferation and an increased tendency toward leukemic transformation. We used targeted next-generation sequencing (NGS) of 104 genes to detect somatic mutations in a cohort of 197 MPN patients and followed clo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-11-537167

    authors: Lundberg P,Karow A,Nienhold R,Looser R,Hao-Shen H,Nissen I,Girsberger S,Lehmann T,Passweg J,Stern M,Beisel C,Kralovics R,Skoda RC

    更新日期:2014-04-03 00:00:00

  • Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome.

    abstract::Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare primary immunodeficiency caused by gain-of-function mutations in the CXCR4 gene. We report the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of mavorixafor from a phase 2 open-label dose-escalatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020007197

    authors: Dale DC,Firkin F,Bolyard AA,Kelley M,Makaryan V,Gorelick KJ,Ebrahim T,Garg V,Tang W,Jiang H,Skerlj R,Beaussant Cohen S

    更新日期:2020-12-24 00:00:00

  • Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops.

    abstract::The biologic effects of endothelin-1 (ET-1) are not limited to its potent vasoconstricting activity. The endothelin receptors, ETA and ETB, have differential tissue and functional distributions. Here we showed that dendritic cells (DCs), the major antigen-presenting cells in the adaptive limb of the immune system, pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-10-3559

    authors: Guruli G,Pflug BR,Pecher S,Makarenkova V,Shurin MR,Nelson JB

    更新日期:2004-10-01 00:00:00

  • Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.

    abstract::We report the outcome of allogeneic bone marrow transplantation (BMT) as treatment for severe combined immunodeficiency disease (SCID) in 31 patients grafted from 1968 until 1992. The patients received a graft from an HLA-identical related (n = 10), an HLA-haplo-identical related (n = 19), or a closely HLA-matched unr...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: van Leeuwen JE,van Tol MJ,Joosten AM,Schellekens PT,van den Bergh RL,Waaijer JL,Oudeman-Gruber NJ,van der Weijden-Ragas CP,Roos MT,Gerritsen EJ

    更新日期:1994-12-01 00:00:00

  • The interaction of platelets with aortic subendothelium: inhibition of adhesion and secretion by prostaglandin I2.

    abstract::We have studied the effect of prostaglandin I2 on platelet turnover, attachment to the subendothelium, and secretion following balloon deendothelialization of the rabbit aorta. Survival of 51Cr-labeled platelets in the balloon-injured animals remained normal. Thirty minutes after injury, there were 4.52 X 10(6) platel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Adelman B,Stemerman MB,Mennell D,Handin RI

    更新日期:1981-08-01 00:00:00

  • Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.

    abstract::The human erythrocyte blood group system Cromer consists of high-incidence and low-incidence antigens that reside on decay-accelerating factor (DAF; CD55), a glycosyl-phosphatidylinositol-anchored membrane protein that regulates complement activation on cell surfaces. In the Cromer phenotypes Dr(a-) and Inab there is ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lublin DM,Mallinson G,Poole J,Reid ME,Thompson ES,Ferdman BR,Telen MJ,Anstee DJ,Tanner MJ

    更新日期:1994-08-15 00:00:00

  • Structural integrity of the glycoprotein IIb and IIIa genes in Glanzmann thrombasthenia patients from Israel.

    abstract::Glanzmann thrombasthenia is an autosomal recessive disorder of the platelet glycoproteins (GP) IIb and IIIa. These glycoproteins normally serve as receptors for other adhesive glycoproteins, including fibrinogen, von Willebrand factor, and fibronectin. Most patients affected by Glanzmann thrombasthenia have low levels...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Russell ME,Seligsohn U,Coller BS,Ginsberg MH,Skoglund P,Quertermous T

    更新日期:1988-11-01 00:00:00

  • Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

    abstract::Primary mediastinal B-cell lymphoma (PMBL) is a subtype of diffuse large B-cell lymphoma (DLBCL) that is putatively derived from a thymic B cell. Accounting for up to 10% of cases of DLBCL, this subtype predominantly affects women in the third and fourth decades of life. Its clinical and molecular characteristics are ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-05-575092

    authors: Dunleavy K,Wilson WH

    更新日期:2015-01-01 00:00:00

  • The human cardiac mast cell: localization, isolation, phenotype, and functional characterization.

    abstract::We have isolated and characterized the human cardiac mast cell (CMC) and compared this novel mast cell (MC type with MC obtained from uterus, skin, and lung. Heart tissue was obtained from 14 patients with cardiomyopathy (CMP, heart transplantation). CMC were isolated by enzymatic digestion using collagenase, pronase-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sperr WR,Bankl HC,Mundigler G,Klappacher G,Grossschmidt K,Agis H,Simon P,Laufer P,Imhof M,Radaszkiewicz T,Glogar D,Lechner K,Valent P

    更新日期:1994-12-01 00:00:00

  • Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?

    abstract::After the discovery of NPM1-mutated acute myeloid leukemia (AML) in 2005 and its subsequent inclusion as a provisional entity in the 2008 World Health Organization classification of myeloid neoplasms, several controversial issues remained to be clarified. It was unclear whether the NPM1 mutation was a primary genetic ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-08-299990

    authors: Falini B,Martelli MP,Bolli N,Sportoletti P,Liso A,Tiacci E,Haferlach T

    更新日期:2011-01-27 00:00:00

  • Setdb1 maintains hematopoietic stem and progenitor cells by restricting the ectopic activation of nonhematopoietic genes.

    abstract::Setdb1, also known as Eset, is a methyltransferase that catalyzes trimethylation of H3K9 (H3K9me3) and plays an essential role in the silencing of endogenous retroviral elements (ERVs) in the developing embryo and embryonic stem cells (ESCs). Its role in somatic stem cells, however, remains unclear because of the earl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-01-694810

    authors: Koide S,Oshima M,Takubo K,Yamazaki S,Nitta E,Saraya A,Aoyama K,Kato Y,Miyagi S,Nakajima-Takagi Y,Chiba T,Matsui H,Arai F,Suzuki Y,Kimura H,Nakauchi H,Suda T,Shinkai Y,Iwama A

    更新日期:2016-08-04 00:00:00

  • Interleukin-4 suppresses plasminogen activator inhibitor-2 formation in stimulated human monocytes.

    abstract::Using a specific enzyme-linked immunosorbent assay, plasminogen activator inhibitor-2 (PAI-2) was quantitated in cultures of human monocytes. Lipopolysaccharide (LPS) increased both extracellular and cell-associated PAI-2 levels, as well as PAI-2 mRNA measured by Northern analysis. Both the lymphokine, interleukin-4 (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hamilton JA,Whitty GA,Last K,Royston AK,Hart PH,Burgess DR

    更新日期:1992-07-01 00:00:00

  • A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.

    abstract::The kidney is involved in 70% of patients with immunoglobulin light-chain (AL) amyloidosis, but little is known on progression or reversibility of renal involvement, and criteria for renal response have never been validated. Newly diagnosed patients from the Pavia (n = 461, testing cohort) and Heidelberg (n = 271, val...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-04-570010

    authors: Palladini G,Hegenbart U,Milani P,Kimmich C,Foli A,Ho AD,Vidus Rosin M,Albertini R,Moratti R,Merlini G,Schönland S

    更新日期:2014-10-09 00:00:00

  • Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics.

    abstract::Overwhelming evidence from leukemia research has shown that the clonal population of neoplastic cells exhibits marked heterogeneity with respect to proliferation and differentiation. There are rare stem cells within the leukemic population that possess extensive proliferation and self-renewal capacity not found in the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-07-2514

    authors: Fang B,Zheng C,Liao L,Han Q,Sun Z,Jiang X,Zhao RC

    更新日期:2005-04-01 00:00:00

  • Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice.

    abstract::Keratinocyte growth factor (KGF) is important in tissue repair and wound healing and its administration can abrogate chemical- and radiation-induced tissue damage in rodents. We investigated KGF as a therapeutic agent for the prevention of graft-versus-host disease (GVHD)-induced tissue damage, morbidity, and mortalit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Panoskaltsis-Mortari A,Lacey DL,Vallera DA,Blazar BR

    更新日期:1998-11-15 00:00:00

  • Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular

    abstract::The Leukemia and Lymphoma Molecular Profiling Project recently published results from DNA microarray analyses of 240 diffuse large B-cell lymphomas (DLBCLs). Four gene expression "signatures" were identified as correlated with patient outcome, including the major histocompatibility complex (MHC) class II genes (eg, HL...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2365

    authors: Rimsza LM,Roberts RA,Miller TP,Unger JM,LeBlanc M,Braziel RM,Weisenberger DD,Chan WC,Muller-Hermelink HK,Jaffe ES,Gascoyne RD,Campo E,Fuchs DA,Spier CM,Fisher RI,Delabie J,Rosenwald A,Staudt LM,Grogan TM

    更新日期:2004-06-01 00:00:00

  • CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia.

    abstract::Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with a complex pathogenesis, which includes both antibody- and T-cell-mediated effector mechanisms. Rituximab (an anti-human CD20 monoclonal antibody [mAb]) is one of the treatments for ITP and is known to deplete B cells but may also work by affecting t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-06-655126

    authors: Guo L,Kapur R,Aslam R,Speck ER,Zufferey A,Zhao Y,Kim M,Lazarus AH,Ni H,Semple JW

    更新日期:2016-02-11 00:00:00